Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22).
Wu X, Wang Y, Cheng L, Ni F, Zhu L, Ma S, Huang B, Ji M, Hu H, Li Y, Xu S, Shi H, Zhang D, Liu L, Nawaz W, Hu Q, Ye S, Liu Y, Wu Z.
Wu X, et al. Among authors: nawaz w.
Front Immunol. 2022 Mar 17;13:865401. doi: 10.3389/fimmu.2022.865401. eCollection 2022.
Front Immunol. 2022.
PMID: 35371009
Free PMC article.